About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Memorial Sloan Kettering Cancer Center
https://www.mskcc.org/healthcare-professionals
Refer a Patient to MSKCC:
mskcc.org/refer
COVID-19
Myeloma
Leukemia
Lymphoma
Hematologic Transplantation and Malignancies
Breast
Lung
Gastrointestinal
Genitourinary
Gynecologic
Skin
Head and Neck
Brain
General Oncology
Palliative Care
Events
MPN
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
A
Treating Elderly Patients with Hodgkin Lymphoma - How Much Bleomycin Is Too Much and the Frontline Brentuximab Vedotin Options
By
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
FEATURING
Alison Moskowitz
By
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
FEATURING
Alison Moskowitz
171 views
October 17, 2019
0 Comments
Login to view comments.
Click here to Login
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Lymphoma
16:05
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: What Is High Risk MCL and How Should We Treat It
Feat.
A. Kumar
21:58
MedNews Week
The Evolving 1L DLBCL Landscape: POLARIX, Novel Agents and Future Di…
Feat.
M. Matasar
24:57
MedNews Week
Current Management of Newly Diagnosed DLBCL
Feat.
M. Matasar
18:10
SOHO Brazil 2023
2023 SOHO® Brazil: "Moving Beyond CHOP/CHOEP - How Disease Feat…
Feat.
A. Moskowitz
38:55
Indy Hematology Review
Managing Indolent and Mantle Cell Lymphomas With Targeted and Cellul…
Feat.
G. Salles
07:46
ASCO 2022 Conference Coverage
ASCO 2022 on the Initial Safety Run-in Results of the Phase III POLA…
Feat.
M. Matasar
05:16
ASCO 2022 Conference Coverage
ASCO 2022 Updated Interim Analysis of the Randomized Phase 1b/3 Stud…
Feat.
C. Lee Batlevi
34
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 Updated Interim Analysis of the Randomiz…
Feat.
C. Lee Batlevi
12:32
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: The Next Wave of Novel Agents in Aggressive B-Cell Lympho…
Feat.
G. Salles
10:28
i3 Health
MSKCC 2021 Update on Therapeutic Advances in T-Cell Lymphoma: Subtyp…
Feat.
S. Horwitz
24:05
SOHO Highlights: State of the Art and Next Questions
SOHO Highlights on Non-Bulky cHL: Can We Treat Early Disease With Sh…
Feat.
D. Straus
11:39
SOHO Highlights: State of the Art and Next Questions
Early Stage cHL Management: Bulky vs. Non-bulky Disease, Better Chem…
Feat.
D. Straus
15:22
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Update on R/R PTCL: Is There a Single Paradigm Overall? Ca…
Feat.
S. Horwitz
21:36
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Highlights on Newly Diagnosed HL: Is ABVD Chemo Regimen Be…
Feat.
D. Straus
09:59
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Updates on R/R cHL: Can We Improve Chemo With ADCs and CPI…
Feat.
D. Straus
11:13
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Update on DLBCL: CAR-T vs. autoHCT for Early Relapsed Dise…
Feat.
S. Giralt
22:53
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
2019 ASH Update on the First-Line Therapy in Follicular Lymphoma: Ri…
Feat.
A. Zelenetz
22:19
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
PI3K Inhibitors Are Highly Active in R/R Follicular Lymphoma, New Do…
Feat.
A. Zelenetz
07:09
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Next Questions in DLBCL: New Genetic Classification Based Selection …
Feat.
A. Younes
15:47
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Who Is a Candidate for Watch and Wait Therapy in MCL / What Are the …
Feat.
A. Kumar
15:41
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
PI3Ki's in Indolent Lymphoma: Overview of Approved Drugs, Trial…
Feat.
A. Zelenetz
15:30
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Marginal Gastric Zone Lymphoma: The Role of Radiation Therapy
Feat.
J. Yahalom
28:25
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Does RCHOP Stay the Standard of Care After 6 Cycles in Advanced/R DL…
Feat.
A. Younes
13:26
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
The Role of Venetoclax in DLBCL: Efficacy and Safety Results from th…
Feat.
A. Zelenetz
11:13
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Treating Elderly Patients with Hodgkin Lymphoma - How Much Bleomycin…
Feat.
A. Moskowitz
23:38
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Ongoing Efforts to Improve the Safety of CAR T-Cell Therapy: Cytokin…
Feat.
B. Santomasso
10:01
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Primary CNS Lymphoma - Clinical Features & Staging, Pretreatment…
Feat.
C. Grommes
13:27
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Treatment of Primary CNS Lymphoma: Upfront Regimen, Surgery, Treatme…
Feat.
C. Grommes
13:57
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Targeted Therapies in CNS Lymphoma & Salvage Options per NCCN Gu…
Feat.
C. Grommes